- Home
- QGEN vs ENSG Comparison
QGEN vs ENSG Comparison
Compare QGEN & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- ENSG
- Stock Information
- Founded
- QGEN 1986
- ENSG 1999
- Country
- QGEN Netherlands
- ENSG United States
- Employees
- QGEN N/A
- ENSG N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- ENSG Hospital/Nursing Management
- Sector
- QGEN Health Care
- ENSG Health Care
- Exchange
- QGEN Nasdaq
- ENSG Nasdaq
- Market Cap
- QGEN 9.1B
- ENSG 7.3B
- IPO Year
- QGEN 1996
- ENSG 2007
- Fundamental
- Price
- QGEN $48.34
- ENSG $150.18
- Analyst Decision
- QGEN Buy
- ENSG Buy
- Analyst Count
- QGEN 9
- ENSG 7
- Target Price
- QGEN $50.79
- ENSG $164.71
- AVG Volume (30 Days)
- QGEN 1.3M
- ENSG 349.6K
- Earning Date
- QGEN 07-30-2025
- ENSG 07-24-2025
- Dividend Yield
- QGEN 3.10%
- ENSG 0.17%
- EPS Growth
- QGEN N/A
- ENSG 39.72
- EPS
- QGEN 0.42
- ENSG 5.30
- Revenue
- QGEN $2,002,874,000.00
- ENSG $4,423,354,000.00
- Revenue This Year
- QGEN $6.36
- ENSG $17.71
- Revenue Next Year
- QGEN $6.18
- ENSG $9.69
- P/E Ratio
- QGEN $114.96
- ENSG $28.34
- Revenue Growth
- QGEN 3.31
- ENSG 14.81
- 52 Week Low
- QGEN $37.63
- ENSG $118.73
- 52 Week High
- QGEN $48.82
- ENSG $158.45
- Technical
- Relative Strength Index (RSI)
- QGEN 70.56
- ENSG 50.74
- Support Level
- QGEN $47.65
- ENSG $147.62
- Resistance Level
- QGEN $48.82
- ENSG $155.81
- Average True Range (ATR)
- QGEN 0.71
- ENSG 3.13
- MACD
- QGEN 0.01
- ENSG -0.92
- Stochastic Oscillator
- QGEN 87.63
- ENSG 25.45
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.